Alignment Healthcare vs Trupanion
ALHC and TRUP side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALHC and TRUP compare
Alignment Healthcare and Trupanion are about the same size, with market caps of $1.6B and $1.5B.
On earnings, Trupanion is cheaper: it trades at 56.2× trailing earnings, against 68.2× for Alignment Healthcare.
Alignment Healthcare grew revenue faster over the last twelve months (35.9% versus 11.4% for Trupanion).
Alignment Healthcare scores higher on the StockData Score (9 against 6 for Trupanion), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALHC | TRUP |
|---|---|---|
| Size and price | ||
| Market cap | $1.6B | $1.5B |
| Share price | $7.50 | $34.30 |
| Change, 1 year | −54.5% | −12.1% |
| Change, 5 years | −65.5% | −74.9% |
| Beta (5Y) | 0.82 | 1.83 |
| Employees | 1,849 | 1,121 |
| StockData Score | ||
| Total score | 9 (better) | 6 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 3 (better) | 0 |
| Health score | 3 | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 68.2× | 56.2× (better) |
| P/S | 0.3× (better) | 1.0× |
| P/B | 5.7× | 3.8× (better) |
| EV/EBITDA | 15.3× (better) | 28.2× |
| P/FCF | 20.4× | 17.4× (better) |
| FCF yield | 4.9% | 5.8% (better) |
| Fair value | $5.04 | $22.76 |
| Margin of safety | −48.8% (better) | −50.7% |
| Growth | ||
| Revenue growth (TTM) | 35.9% (better) | 11.4% |
| Revenue growth, 5Y average | 32.7% (better) | 23.4% |
| EPS growth (TTM) | – | 69.4% |
| Profitability | ||
| Gross margin | – | 16.7% |
| Operating margin | 0.88% | 1.8% (better) |
| Net margin | 0.59% | – |
| FCF margin | 1.6% | 5.6% (better) |
| Return on equity | 13.2% | – |
| Return on invested capital | – | 23.9% |
| Financial health | ||
| Debt / equity | 1.17 | 0.26 (better) |
| Net debt / EBITDA | −5.57 | −6.79 |
| Interest coverage | 2.6× | 2.9× (better) |
| Current ratio | 1.71 | 1.74 (better) |
| Altman Z-score | 4.25 (better) | 3.63 |
| Piotroski F-score | 5 | – |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 106% | 77.1% |
| Held by insiders | 4.6% | 5.9% |
| Insider net buying, 12 months | −$517M | −$1.8M (better) |
| Short interest, % of float | 11.6% | 9.5% |
Go deeper
- ALHC stock overview
- ALHC income statement
- ALHC valuation and score
- TRUP stock overview
- TRUP income statement
- TRUP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.